While the precise role of NLRP3 in the initiation of CE remains unclear, it may modulate the Th17/Treg balance, as observed in patients with RPL (51) and CE (52), potentially altering the immune environment of the endometrium. This evidence concerns the gene NLRP3 and cholesteryl ester measurement.